This easy-to-use service reshapes how you think about presentations, documents, and even websites by letting you pass all the design work off to AI.

PowerPoint now offers AI-powered design suggestions via Copilot, helping users overcome creative blocks and design slides ...

A copy of each poster presentation is available on the Scientific Resources page of the Repare Therapeutics website and a copy of each mini-oral presentation will be available on the Scientific ...

CHICAGO, April 25, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that 18 ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that 18 abstracts, including one oral presentation ...

The result of the verification methods, when successful, also conveniently contain the decoded and parsed payloads, in a format that closely matches the W3C data model for verifiable credentials and ...

today announced eight abstracts have been accepted for poster presentations at the European Association for the Study of the Liver (EASL) Congress 2025, being held May 7 - 10, 2025 in Amsterdam, ...

Presenter: Katharine Price, M.D., Associate Professor of Oncology, Head and Neck Disease Group, Mayo Clinic Comprehensive Cancer Center, and Principal Investigator of the VERSATILE-003 clinical ...

today announced eight abstracts have been accepted for poster presentations at the European Association for the Study of the Liver (EASL) Congress 2025, being held May 7 – 10, 2025 in Amsterdam ...

today announced that several abstracts highlighting the Company's innovative assets have been selected for presentation at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting ...

Go from text prompts to slide decks in minutes with CNET's guide on creating a PowerPoint presentation ... Prezi AI promises to create "your best presentation in minutes." Let's see about that.

today announced that an abstract highlighting new, highly encouraging, Overall Survival data from the Phase 2 OVATION 2 Study of IMNN-001 to treat women with newly diagnosed advanced ovarian cancer ...